PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18593727-0	2008	PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742.	GW0742	115-121	peroxisome proliferator activated receptor alpha	Mus musculus	0-10	
23499837-3	2013	In this study, we determined if the peroxisomal proliferator-activated receptor (PPAR) delta agonist GW0742 can prevent radiation-induced brain injury in C57Bl/6 wild-type (WT) and PPARdelta knockout (KO) mice.	GW0742	101-107	peroxisome proliferator activated receptor alpha	Mus musculus	36-79	
23499837-3	2013	In this study, we determined if the peroxisomal proliferator-activated receptor (PPAR) delta agonist GW0742 can prevent radiation-induced brain injury in C57Bl/6 wild-type (WT) and PPARdelta knockout (KO) mice.	GW0742	101-107	peroxisome proliferator activated receptor alpha	Mus musculus	81-85	
33790957-6	2021	The selective PPARbeta/delta agonist GW0742 significantly decreased inflammation-related mRNA expression in hDPCs (IL6, IL1beta, TNFalpha, MMP1, and MMP2) and RAW264.7 cells (Il6 and Tnfalpha).	GW0742	37-43	peroxisome proliferator activated receptor alpha	Mus musculus	14-28	
31939088-3	2020	The present study was undertaken to evaluate the protective effects of PPAR-beta/delta activation using a selective PPAR-beta/delta agonist, GW0742, against brain injury after ICH in a mouse model.	GW0742	141-147	peroxisome proliferator activated receptor alpha	Mus musculus	71-80	
31939088-3	2020	The present study was undertaken to evaluate the protective effects of PPAR-beta/delta activation using a selective PPAR-beta/delta agonist, GW0742, against brain injury after ICH in a mouse model.	GW0742	141-147	peroxisome proliferator activated receptor alpha	Mus musculus	116-125	
31939088-10	2020	Mice treated with GW0742 showed significantly less severe behavioral deficits compared to the control group, accompanied by increased expression of PPAR-beta/delta and Bcl-2, and increased expression of IL-1beta, TNF-alpha, and Bax decreased simultaneously in the GW0742-treated group.	GW0742	18-24	peroxisome proliferator activated receptor alpha	Mus musculus	148-163	
27150147-0	2016	Pulmonary Administration of GW0742, a High-Affinity Peroxisome Proliferator-Activated Receptor Agonist, Repairs Collapsed Alveoli in an Elastase-Induced Mouse Model of Emphysema.	GW0742	28-34	peroxisome proliferator activated receptor alpha	Mus musculus	52-94	
18593727-0	2008	PPAR alpha, more than PPAR delta, mediates the hepatic and skeletal muscle alterations induced by the PPAR agonist GW0742.	GW0742	115-121	peroxisome proliferator activated receptor alpha	Mus musculus	0-4	
14684157-9	2004	GW0742 can restore partly the expression of certain key genes of fatty acid oxidation in mouse adult cardiomyocytes isolated from PPARalpha knockout mice.	GW0742	0-6	peroxisome proliferator activated receptor alpha	Mus musculus	130-139	
35461240-7	2022	Through specific DNA fragmentation quantification and qRT-PCR experiments, we evidenced in vitro an increased resistance to oxidative stress in MSC pre-treated by the PPARbeta/delta agonist GW0742 versus naive MSC.	GW0742	190-196	peroxisome proliferator activated receptor alpha	Mus musculus	167-181